Goodrx Holdings, Inc. Stock Price, News & Analysis

GoodRx (GDRX) has released a report revealing significant gender disparities in prescription medication costs. In 2024, women spent $8.8 billion more than men on out-of-pocket prescription costs, representing a 30% higher expenditure.

Key findings show women spent nearly $40 billion in total out-of-pocket prescription costs, with female-specific conditions exceeding $1.5 billion. The gender gap is most pronounced among women aged 18-44, who spend up to 64% more than men of the same age group. Women also outspend men significantly on mental health treatments, paying 113% more for depression medications and 103% more for anxiety treatments.

To address this disparity, GoodRx offers savings at over 70,000 pharmacies nationwide, including discounts up to 43% on fertility treatments and special pricing for menopause therapies ($99-$249 range).

GoodRx Holdings (NASDAQ: GDRX) has reported its Q4 and full-year 2024 financial results. For FY2024, the company achieved revenue of $792.3 million, a 6% increase from the previous year, with a net income of $16.4 million and a net income margin of 2.1%.

Key financial metrics include Adjusted EBITDA of $260.2 million with a 32.8% margin, and net cash from operations of $183.9 million. The company's prescription transactions revenue grew 5% to $577.5 million, while pharma manufacturer solutions revenue increased 26% to $107.2 million. However, subscription revenue decreased 8% to $86.5 million.

The company maintains a strong financial position with cash and cash equivalents of $448.3 million and total debt of $500.0 million. GoodRx serves nearly 30 million consumers and over one million healthcare professionals annually, having helped Americans save over $85 billion on medication costs since 2011.

GoodRx (Nasdaq: GDRX) has announced that its drug savings platform on AWS has earned HITRUST i1 Certification for 2025, validating its commitment to data protection and cybersecurity. The certification covers AWS data centers in California, Ohio, Oregon, and Virginia, demonstrating the company's adherence to specific security standards and controls against current and emerging threats.

The certification requires annual third-party audits and reinforces GoodRx's position in healthcare data protection. As the leading medication savings platform in the U.S., GoodRx serves nearly 30 million consumers and over one million healthcare professionals annually. Since 2011, the company has helped Americans save over $75 billion on medication costs by connecting consumers, healthcare professionals, payers, PBMs, pharma manufacturers, and retail pharmacies.

GoodRx (GDRX) has appointed Christopher A. McGinnis as its new Chief Financial Officer, effective February 4, 2025. McGinnis brings 30 years of healthcare industry financial experience to the role. He joins from his position as CEO of CitizensRx, where he led pharmacy benefit management services. Previously, he served as CFO and Executive VP of Operations at Lumeris / Essence Healthcare, and as Chief Accounting Officer at Express Scripts Holding Company.

McGinnis will work alongside CEO Wendy Barnes, who previously worked with him at Express Scripts. In his new role, he will focus on helping GoodRx advance its mission of making healthcare more affordable and accessible for Americans while driving growth and stakeholder value.

GoodRx Holdings (Nasdaq: GDRX), the leading prescription savings platform in the U.S., has announced its schedule for the release of fourth quarter and full year 2024 financial results. The company will release its financial report before U.S. markets open on Thursday, February 27, 2025.

Management will hold a conference call and webcast at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) on the same day to discuss results and business outlook. Interested parties must pre-register to access the conference call, and will receive confirmation with dial-in details and a unique passcode. The call will be webcast live on the company's investor relations website, where presentation materials will be available before the call. An archived version of the webcast will be accessible for at least 30 days after the live call.

GoodRx Holdings (Nasdaq: GDRX) announced that Scott Wagner has joined its Board of Directors as Co-Chair, effective January 21, 2025. Wagner, who served as Interim CEO from April 2023 to January 2025, will serve alongside existing Co-Chair Trevor Bezdek and chair the Board's Compensation Committee.

Wagner brings over 25 years of executive leadership experience, notably as CEO, President, COO, and CFO at GoDaddy, where he helped triple revenue to nearly $3 billion and expanded services globally. Previously, he was a Partner at KKR from 2000 to 2012, leading the Capstone team.

The appointment coincides with Simon Patterson's resignation from the board, including his positions on the Nominating and Corporate Governance Committee and Innovation Committee.

GoodRx (GDRX) has announced free online healthcare provider visits for California residents affected by the Los Angeles County wildfires. Using the code LA-GOODRX-CARE, residents can access GoodRx Care for various medical conditions and prescription refills, regardless of insurance status.

The initiative allows affected residents to consult with licensed medical professionals who can refill existing medications and send prescriptions to local pharmacies. The company is also providing guidance on accessing emergency refills through insurance companies, saving up to 80% on prescriptions using GoodRx, and transferring prescriptions to different pharmacies if needed.

As a Santa Monica-based company, GoodRx aims to ensure community members can maintain access to essential medications and healthcare during the wildfire crisis, particularly for those who may have lost or left behind medications during evacuation.

GoodRx (GDRX) has launched 'GoodRx for Pets,' a new platform offering savings and home delivery for pet medications. The service aims to address the rising cost of pet healthcare, which saw Americans spend over $13 billion on pet medications in 2023. With pet care prices increasing 25% in the last five years and only 3% of pets having insurance coverage, the platform offers up to 80% savings on medications at over 70,000 retail pharmacies nationwide.

The new service, powered by Allivet, includes an integrated e-commerce experience for direct-to-door delivery and access to pet-specific medications not available in retail pharmacies. The platform also provides expert-created educational content on pet health. GoodRx reports that pet owners have already been using their platform for millions of prescriptions annually, prompting this dedicated pet-focused expansion.

WM Technology (Nasdaq: MAPS) has appointed Sarah Griffis as its new Chief Technology Officer, effective January 6, 2025. Griffis brings experience from regulated industries, having previously served as CTO at Cerebral, a digital healthcare company, and held engineering leadership positions at GoodRx and Kindbody.

CEO Doug Francis expressed enthusiasm about Griffis joining the cannabis marketplace and technology solutions provider, highlighting her experience in building engineering teams and operating in regulated industries. Griffis, a Caltech graduate in Environmental Science Engineering, stated her commitment to improving the company's product and creating greater efficiencies for customers and clients.